Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50

Recall Number: D-0288-2021

Firm: The General Hospital Corporation

Classification: Class II

Status: Terminated

Report Date: 20210303

Initiation Date: 20210217

Termination Date: 20210326

Lack of Assurance of Sterility

Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50